Goldfinch Health Selected to Advance in Innovation Program
Canada-based Creative Destruction Lab providing mentoring and support to enhance commercialization efforts for US-based surgery and recovery leader
January 27, 2021 – On the heals of its selection as a pitch contest winner at the Calgary-based 2020 Inventures, Goldfinch Health has announced participation in another Canadian program designed to drive health innovation and commercialization in North America and beyond. Following a rigorous application process, Creative Destruction Lab (CDL) invited Goldfinch to participate in its widely-recognized program and has now advanced the company through two rounds of mentoring and development efforts.
“We are tremendously grateful for the opportunity to network with and learn from the distinguished leaders and entrepreneurs in the CDL community,” said Brand Newland, PharmD, CEO of Goldfinch Health. “This is a direct hit for us. We’ve been able to immediately translate discussions in our CDL sessions to improving our program, and, as a result, to improving patient outcomes.”
CDL Health, built for founders pursuing commercial opportunities predicated on translational science and technology innovations that improve human health and wellness, helps technical teams bring their health innovations to market by providing access to industry-leading mentors and investors in the life sciences domain.
Example innovation areas for CDL Health include:
- Diagnostics tools and platforms
- Digital Health
- Medical Devices
- Precision medicine and pharmacogenomics
- Therapeutics, biopharmaceuticals, and other drug discovery
There are no fees for participation in the program and CDL does not take any equity in participating companies.
About Creative Destruction Lab
Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. Its nine-month program allows founders to learn from experienced entrepreneurs, increasing their likelihood of success. Founded in 2012 by Professor Ajay Agrawal at the Rotman School of Management at University of Toronto, the program has expanded to eight sites across four countries: Oxford (Saïd Business School, University of Oxford), Paris (HEC Paris), Atlanta (Scheller College of Business, Georgia Institute of Technology), Vancouver (Sauder School of Business, University of British Columbia), Montreal (HEC Montréal), Calgary (Haskayne School of Business, University of Calgary), and Halifax (Rowe School of Business, Dalhousie University). The successful commercialization of cutting-edge science and technology achieved through the program has led to the creation of over $6.7 billion in equity value. CDL alumni companies include North (Waterloo), Atomwise (San Francisco), Kyndi (Palo Alto), Xanadu (Toronto), BenchSci (Toronto), Kheiron Medical (London), and Roadbotics (Pittsburgh).
About Goldfinch Health
Goldfinch Health (www.goldfinchhealth.com) optimizes the surgery and recovery experience within existing health insurance networks, saving companies and employees time, money and addiction. Through the power of Enhanced Surgical Pathways and expert nurse care guidance, Goldfinch aims to reduce the nearly $40 billion American companies lose each year due to unnecessarily-invasive surgery and recovery. In addition, Goldfinch offers a novel, proactive solution to address the opioid epidemic and has demonstrated a reduction in post-surgical opioid painkiller use by up to 90%.